CT Scanning in COPD - Is It Time to Move On?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Dirksen A, Dijkman J, Madsen F, Stoel B, HUTCHISON D, Ulrik C
. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med. 1999; 160(5 Pt 1):1468-72.
DOI: 10.1164/ajrccm.160.5.9901055.
View
2.
Dowson L, Guest P, Stockley R
. Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline. Am J Respir Crit Care Med. 2001; 164(10 Pt 1):1805-9.
DOI: 10.1164/ajrccm.164.10.2106036.
View
3.
Vestbo J, Anderson W, Coxson H, Crim C, Dawber F, Edwards L
. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J. 2008; 31(4):869-73.
DOI: 10.1183/09031936.00111707.
View
4.
Pedersen J, Ashraf H, Dirksen A, Bach K, Hansen H, Toennesen P
. The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round. J Thorac Oncol. 2009; 4(5):608-14.
DOI: 10.1097/JTO.0b013e3181a0d98f.
View
5.
Han M, Agusti A, Calverley P, Celli B, Criner G, Curtis J
. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010; 182(5):598-604.
PMC: 6850732.
DOI: 10.1164/rccm.200912-1843CC.
View